Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1NETWORK 1INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 25Ovarian Neoplasms 23Breast Neoplasms 22Lung Neoplasms 19Lymphoma 18Carcinoma, Ovarian Epithelial 18Neoplasm Metastasis 14Colorectal Neoplasms 14Squamous Cell Carcinoma of Head and Neck 12Sarcoma 12Head and Neck Neoplasms 12Urinary Bladder Neoplasms 10Prostatic Neoplasms 10Colonic Neoplasms 10Central Nervous System Neoplasms 10Astrocytoma 10Rectal Neoplasms 9Multiple Myeloma 9Uterine Cervical Neoplasms 8Oligodendroglioma 8Mycosis Fungoides 8Fallopian Tube Neoplasms 8Adenocarcinoma of Lung 8Stomach Neoplasms 7Recurrence 7Melanoma 7Medulloblastoma 7Brain Neoplasms 7Sezary Syndrome 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Interventions

Urination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × NETWORK × Spinal Cord Injuries × Clear all
NCT02538809 2025-02-13

Novel mRNA-based Urine Test for Bladder Cancer in Spinal Cord Injury Individuals

Swiss Paraplegic Research, Nottwil

Terminated
50 enrolled
Genitourinary

Urinary Bladder Neoplasms, Spinal Cord Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡